NFS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.709400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.122400E-01
Normal-vs-Stage2
9.586600E-01
Normal-vs-Stage3
1.653200E-01
Normal-vs-Stage4
4.606600E-01
Stage1-vs-Stage2
1.824170E-01
Stage1-vs-Stage3
2.883500E-02
Stage1-vs-Stage4
4.424000E-01
Stage2-vs-Stage3
1.000650E-01
Stage2-vs-Stage4
6.985000E-01
Stage3-vs-Stage4
4.056100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.446000E-01
Normal-vs-AfricanAmerican
6.615000E-01
Normal-vs-Asian
3.193000E-01
Caucasian-vs-AfricanAmerican
6.100600E-01
Caucasian-vs-Asian
2.076100E-02
AfricanAmerican-vs-Asian
2.272400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.310200E-01
Normal-vs-Female
9.289600E-01
Male-vs-Female
6.154400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.413600E-01
Normal-vs-Age(41-60Yrs)
5.967200E-01
Normal-vs-Age(61-80Yrs)
9.009200E-01
Normal-vs-Age(81-100Yrs)
6.908200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.204000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.170000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.039800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.433610E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.021000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.210600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.882400E-01
Normal-vs-Daily Drinker
6.788800E-01
Normal-vs-Weekly Drinker
7.179800E-01
Normal-vs-Occasional Drinker
4.161400E-01
Normal-vs-Social Drinker
6.456600E-01
Non Drinker-vs-Daily Drinker
8.737700E-02
Non Drinker-vs-Weekly Drinker
9.629800E-02
Non Drinker-vs-Occasional Drinker
1.187790E-02
Non Drinker-vs-Social Drinker
1.096170E-01
Daily Drinker-vs-Weekly Drinker
7.504600E-01
Daily Drinker-vs-Occasional Drinker
8.747600E-01
Daily Drinker-vs-Social Drinker
9.832000E-01
Weekly Drinker-vs-Occasional Drinker
7.588400E-01
Weekly Drinker-vs-Social Drinker
7.558800E-01
Occasional Drinker-vs-Social Drinker
9.012200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.538400E-01
Normal-vs-Grade 2
9.354600E-01
Normal-vs-Grade 3
9.723600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.800000E-01
Grade 1-vs-Grade 3
5.653200E-01
Grade 1-vs-Grade 4
9.538400E-01
Grade 2-vs-Grade 3
2.440400E-01
Grade 2-vs-Grade 4
9.354600E-01
Grade 3-vs-Grade 4
9.723600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.509800E-01
Normal-vs-NonDiabetic
7.564200E-01
Diabetic-vs-NonDiabetic
3.764100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.410400E-01
Normal-vs-NoPancreatitis
9.135600E-01
Pancreatitis-vs-NoPancreatitis
3.679000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.613800E-01
Normal-vs-N1
9.536400E-01
N0-vs-N1
3.495200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.178000E-01
Normal-vs-TP53-NonMutant
7.732000E-01
TP53-Mutant-vs-TP53-NonMutant
6.054600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
